baber/WOPTO huggingface dataset:
Patent IE-41605-L (IE)
Title: A tetrapeptide amide
IPC: A61K38/04
Filed: 1975-08-27
Abstract: 1478553 #-Alanine derivatives F HOFFMANN-LA ROCHE & CO AG 27 Aug 1975 [28 Aug 1974] 35358/75 Heading C2C [Also in Division C3] In the examples, compounds prepared are: #-alanine methyl ester hydrochloride is prepared by the esterification of #-alanine with methanol in hydrochloric acid, and converted to t-butyl- Oxycarbonyl - L - prolyl - # - alanine methyl ester on reaction with t-butyloxycarbonyl-L-proline, which is converted to t-butyloxycarbonyl-L-prolyl-#-alaninamide on treatment with ammonia, which yields L-prolyl-#-alaninamide on treatment with hydrogen chloride. Benzyloxycarbonyl - # - alaninamide was prepared by the action of ammonia on benzyloxycarbonyl-#-alanine, and converted to #-alaninamide by hydrogenation, which yields benzyloxycarbonyl - L - prolyl - # - alaninamide on reaction with benzyloxycarbonyl - L - prolyl - p - nitrophenyl ester, which gives L-prolyl-#-alaninamide on hydrogenation. Benzyloxycarbonyl - L - prolyl - # - alaninemethyl ester is prepared by the reaction of #- alanine methyl ester hydrochloride and benzyloxycarbonyl-L-proline, and yields L-prolyl-#- alanine methyl ester on hydrogenation.
[GB1478553A]
Patent IE-891936-L (IE)
Title: Chemical compounds
IPC: C07D213/81
Filed: 1989-06-15
Abstract: Compounds of the formula (1) : <CHEM> or pharmaceutically acceptable salts thereof as described, wherein <CHEM> is a pyridine, pyrazine or triazine ring; R<1> is C1-6alkyl, C2-6alkenyl, C3-5cycloalkylC1-6alkyl, or C1-6alkyl substituted by 1 to 6 fluoro groups; R<2> is C1-6alkylthio, C1-6alkylsulphonyl, C1-6alkoxy, hydroxy, hydrogen, hydrazino, C1-6alkyl, phenyl, -NHCOR<3> wherein R<3> is hydrogen or C1-6alkyl, or -NR<4>R<5>, wherein R<4> and R<5> together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, hexahydroazepino, morpholino or piperazino ring, or R<4> and R<5> are independently hydrogen, C3-5cycloalkyl or C1-6alkyl which is optionally substituted by -CF3, phenyl, -S(O)nC1-6alkyl wherein n is 0, 1 or 2, -OR<6>, -CO2R<7> or -NR<8>R<9> wherein R<6> to R<9> are independently hydrogen or C1-6alkyl, provided that the carbon atom adjacent to the nitrogen atom is not substituted by said -S(O)nC1-6alkyl, -OR<6> or -NR<8>R<9> groups; and when <CHEM> is a pyrazine ring it may be further substituted by hydroxy when R<2> is hydroxy. Their use as medicaments, pharmaceutical compositions comprising them and processes for their preparation are also described.
[EP0347146A2]
Patent IE-832047-L (IE)
Title: Valve
IPC: F16K3/08
Filed: 1983-09-01
Abstract: 1. Upper cartridge part for a sanitary single shut off valve, comprising a head piece (2) which can be screwed into a standard aperture and can be sealed by means of an O-ring (3), a spindle (4) provided with an end journal bearing (8), a movable sealing disc (20) driven by the spindle, a fixedly arranged sealing disc (23), and a seal (24), arranged in the lower part of the head piece, which presses the sealing surfaces of the sealing discs against each other when the head piece is tightened, whereby the sealing discs are provided with water apertures (29, 31), and by adjustment of an appropriate angular position the water passage can be determined, characterized in that a) the end journal bearing (8) of the spindle (4) is mounted in a closed grease chamber (7), (b) the sealing ring (24) is retained between a coarse filter (26) and a thrust ring (28) and is fixedly arranged in the head piece.
Patent IE-842178-L (IE)
Title: detergent compositions
IPC: C11D3/37
Filed: 1984-08-24
Abstract: Detergent compositions comprising from about 5% to about 60% organic surfactant, from about 7% to about 80% detergency builder essentially free of phosphate and a bleach system. The detergency builder has defined calcium builder capacity and defined magnesium: calcium selectivity and is preferably a mixture of an aluminosilicate and a polycarboxylate. The bleach system comprises peroxy bleaching agent, heavy metal scavenging agent and preferably a bleach activator. The compositions combine excellent bleach stability, fabric damage characteristics and detergency performance.
[EP0137669A1]
Patent IE-38681-L (IE)
Title: Imidazotriazines
IPC: C07D253/075
Filed: 1973-12-31
Abstract: 1457873 Pharmaceutical compositions ALLEN & HANBURYS Ltd 13 Dec 1973 [4 Jan 1973] 553/73 Heading A5B [Also in Division C2] Pharmaceutical compositions having spasmolytic, xanthineoxidase- and phosphodiesterase-inhibiting, cardiotonic and diuretic activity comprise as active ingredient, a 2-aminoimidazo[5, 1-f]-as-triazine of the general formula wherein each of R 1 and R 2 is a hydrogen atom. or an alkyl, aralkyl, alkanoyl, aroyl or alkanesulphonyl group, R 3 is a hydrogen atom or an alkyl, aralkyl, alkenyl, aryl or alkylthio group, R 4 is a hydrogen atom or an alkyl group, R 5 is a hydrogen atom or an aryl, alkyl or C 3-7 cycloakyl-alkyl group and the dotted line indicates an optional 3, 4-bond; or a derivative thereof formed by nucleophilic addition across the 3, 4-double bond, or a physiologically acceptable acid addition salt thereof in association with a pharmaceutical carrier or diluent and optionally a #-adrenoreceptor stimulant e.g. salbutamol or isoprenaline, and may be administered orally, parenterally, topically or by inhalation.
[GB1457873A]
Patent IE-872667-L (IE)
Title: Pharmaceutical compositions
IPC: A61K31/575
Filed: 1987-10-06
Abstract: Pharmaceutical compsns. for oral admin. comprise (a) a drug whose bioavailability is increased in the presence of an absorption promoter, (b) chenodeoxycholic acid, deoxycholic acid or their salts, (c) a carrier, and opt. (d) a synergist for component (b).
[EP0263493A2]
Patent IE-42070-L (IE)
Title: Manufacture of tampons
IPC: A61F13/20
Filed: 1975-12-09
Abstract: Apparatus and procedures for forming and filling tampon sacks with absorptive aggregate in a continuous, high speed operation, the aggregate being delivered in uniform condition to a loading gun comprising a rotary loading wheel having pockets into which measured charges of aggregate are drawn by vacuum; the loading gun delivers the charges of aggregate to a discharge nozzle which propels the discrete charges through a hollow mandrel about which a web of sack forming material is tubed, the tubing upon passing beyond the mandrel being pinched between a lugged belt and a rotary transfer wheel at spaced apart intervals corresponding to the length of the tampon sacks being formed, as defined by preprinted transverse adhesive stripes on the tubed web, the discrete charges of aggregate being captured between adjacent pairs of lugs on the belt; the filled tubing is maintained in contact with the transfer wheel by vacuum until released for delivery to a succeeding operating station, a transfer tube being provided to deliver the filled tubing to the succeeding operating station in proper orientation for closing and sealing the ends of the sacks being formed, the transfer wheel including adjustment means to maintain accurate registry of the filled tubing during transfer.
[US4019306A]
Patent IE-892745-L (IE)
Title: Pharmaceutical Composition
IPC: A61K31/4738
Filed: 1989-08-25
Abstract: A pharmaceutical composition comprising 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8- dicarboxyl ic acid or a pharmaceutically acceptable salt thereof, a pressurised or liquefied gas propellant, and a flavouring agent and/or a sweetening agent is useful in the treatment of reversible obstructive airways disease. The composition preferably contains nedocromil sodium as active ingredient. Flavouring agents which may be used include menthol and peppermint oil. Sweetening agents which may be used include sugar, aspartame, cyclamates and saccharin or salts thereof. The composition preferably includes both a flavouring agent and a sweetening agent. Any conventional aerosol propellant may be used, eg a mixture of Propellant 12 and Propellant 114, and the composition is preferably packaged in a conventional pressurised aerosol canister fitted with a dispensing metering valve.
Patent IE-822820-L (IE)
Title: Imidazole and triazole microbiocidal compounds
IPC: C07D233/60
Filed: 1982-11-26
Abstract: Novel substituted azolyl-ethyl ethers of the general formula I   <IMAGE>  wherein R1 is phenyl, phenyl mono- to trisubstituted by halogen, C1-C3- haloalkyl, nitro, C1-C3-alkoxy, C1-C8-alkyl and/or cyano, or phenyl substituted by phenyl or phenoxy, naphthyl, or naphthyl mono- or -disubstituted by halogen, nitro and/or C1-C3-alkyl, benzyl, or benzyl mono- or disubstituted by halogen, nitro and/or C1-C3-alkyl; R2 is phenyl, phenyl mono- to trisubstituted by halogen, C1-C3-haloalkyl, nitro, C1-C3-alkoxy, C1-C8-alkyl and/or cyano, or phenyl substituted by phenyl or phenoxy, or it is C1-C10-alkyl, C3-C8-cycloalkyl or C3-C8- cycloalkyl-(C1-C4-alkyl); R3 is C1-C12-alkyl, C2-C4-alkenyl, C3-C4-alkynyl, benzyl, or benzyl mono- or disubstituted by halogen, nitro and/or C1-C3-alkyl; and R4 is an azolyl group; including acid addition salts thereof, quaternary azolium salts and metal complexes, are used in agrochemical compositions for the preventive and curative combating of harmful microorganisms.
Patent NO-820861-L (NO)
Title: Prefabrikert gulvelement med innebygget varme-element
Inventor: BONDEVIK DAGFINN
IPC: E04B/
Filed: 1982-03-17
Abstract: Prefabrikert gulvelement i flateutstrekning stort som hele rommet med innebygget varmeelement for-trinnsvis til bruk i våtrom som bad etc.Henv. til figuren:. a = vanntett belegg, b= spikerslag c= laminatplate, d= metallplate e= tape, f= isolasjon, g= varme-element.
Patent NO-831167-L (NO)
Inventor: SCHWEISS PETER
IPC: D21F1/70
Filed: 1983-03-29
Abstract: 1. Flotation apparatus having an injector serving to introduce a mixture of gas and fluid into the flotation apparatus, the injector having a constriction and a mixing section (5) behind this and also a gas intake guided centrally into the constriction, characterised by the following features of the injector : a) the constriction (3, 4) widens abruptly towards the mixing section (5), b) the centrally guided gas intake (6) ends a short distance behind the constriction (3, 4) in the mixing section (5), c) the mixing section (5) has a second constriction (7) widening like a diffusor.
Patent NO-850603-L (NO)
Inventor: MILNER JEREMIAH
IPC: A61M1/28
Filed: 1985-02-15
Abstract: A pertitoneal dialysis composition contains an osmotic agent comprising a glucose polymer mixture, said mixture including more than 50% by weight of glucose polymers of D.P. (degree of polymerisation) greater than 12. A method of effecting peritoneal dialysis comprises introducing into the abdominal cavity of a patient such a peritoneal dialysis composition. A method of treating a patient suffering from toxaemia caused other than by kidney malfunction comprises effecting peritoneal dialysis by introducing into the abdominal cavity of the patient a peritoneal dialysis composition including as an osmotic agent a glucose polymer mixture containing at least 15% by weight of glucose polymers of D.P. greater than 12.
Patent NO-851863-L (NO)
Inventor: PAL GAL
IPC: B23K20/16
Filed: 1985-05-10
Abstract: A coherent bond is formed for thin metallic sheets by hot press welding an auxiliary deformable material to the sheets to be bonded together. During application of a force to the deformable material, the oxide layer on the metallic structural elements is physically moved by the deformation of the auxiliary deformable material. In this manner, the auxiliary deformable material is directly bonded to clean metal and is built into the crystalline lattice structure of the thin metallic elements to thereby produce a coherent bond.
Patent NO-863871-L (NO)
Title: Fremgangsmaate for fremstilling av en kjoetterstatning.
Inventor: NGUYEN GUY D T
IPC: A23J3/00
Filed: 1986-09-29
Abstract: Fremgangsmåte for fremstilling av et næringsmiddel fra vegetabilsk protein. Produktet bar en flberstruktur som naturlig muskel og konsistens og utseende som kjøtt. Fremgangsmåten Innbefatter fremstilling av en blanding av vegetabilsk protein og vann. Blandingen blir deretter oppvarmet og ekspandert. Den ekspanderte blanding orienteres ved å utøve trykk i to dimensjoner mens blandingen får bevege seg i den tredje dimensjonen. Produktet er bemerkelsesverdig likt naturlig kjøtt med en makroskopisk fiberstruktur om-fattende parallelle og sylindriske makroskopiske fibrer bestående av vesentlig inn-rettede og sylindriske mikrofibriler. Dessuten er både de makroskopiske fibrene og mikrofibrilene vesentlige frie for en nettformet struktur.
Patent NO-885030-L (NO)
Inventor: ELLIOTT LAURA
IPC: F21K2/06
Filed: 1988-11-11
Abstract: A chemiluminescent device is disclosed wherein a first polymeric sheet having a shaped cavity therein is sealed around its periphery to a second polymeric sheet and the cavity contains 1) an absorbent article produced from a polyolefin, or a polyester or glass fibers and being of substantially the same shape as the cavity and 2) a sealed receptacle containing a first liquid component of a chemiluminescent light composition and wherein there is also present, outside said sealed receptacle, a second liquid component of a chemiluminescent light composition, said absorbent article conforming to seven critical chemical limitations.
Patent NO-890200-L (NO)
Inventor: CUER JEAN-PIERRE
IPC: B01D21/01
Filed: 1989-01-17
Abstract: A basic aluminium chlorosulphate whose basicity is between 45 and 70 % and in which more than 80 % of the SO4<2><-> ions are complexed. This product is prepared by reaction of calcium carbonate with an aluminium chlorosulphuric solution. This product can be used for coagulating and flocculating suspended matter in water, in particular with the aim of preparing potable water. An advantage of the product of the invention is that it leaves very little residual aluminium in the water produced.
Patent NO-891856-L (NO)
Inventor: KNOBEL THOMAS M
IPC: C08K5/00
Filed: 1989-05-05
Abstract: This invention relates to an antistatic additive for polymers, particularly polyurethanes. The additive comprises an ionizable metal salt of a fluoroalkyl sulfonic acid and an enhancer. The enhancer is generally a salt or ester of a carboxylic acid or a phosphate ester. A substantial increase in conductivity or static dissipative properties over that of the organic polymer alone is obtained by incorporating the additive into the polymer composition.
Patent NO-904915-L (NO)
Inventor: HENGELMOLEN ADRIANUS JACOBUS
IPC: F04D29/30
Filed: 1990-11-13
Abstract: The fan blades (40) of a hot gas blower (10) are cooled by the forced passage of cooling air or gas through the blades(40), the cooling air or gas being vented either into the hot gases or being solated therefrom and being recirculated after cooling.
Patent NO-904935-L (NO)
Inventor: LUNDIN BJOERN-ERIC
IPC: G05D7/01
Filed: 1990-11-14
Abstract: The present invention relates to a method of controlling a fluid-flow regulating device, in which a pressure or pressure difference in a flow duct is maintained at a selected, substantially constant value, and in which the regulating device is driven via an operating unit through the influence of the actual fluid itself. The pressure or pressure difference is caused to act on a lever device in a manner to hold the lever in a position of equilibrium between its two terminal positions of rotation when the selected value of the pressure or pressure difference is reached. The operating unit is emptied essentially completely of fluid by the ejector effect provided by the removed fluid flow, when so required for control purposes, and the flow of fluid into an out of the operating unit respectively is controlled in response to the position of the lever device. The invention also relates to an arrangement for controlling a regulating device.
Patent NO-923703-L (NO)
Inventor: GLUECK REINHARD
IPC: A61K47/48
Filed: 1992-09-24
Abstract: The phospholipid bi-layer vesicle contains at least one pharmaceutically active drug and comprises cell-specific markers on the membrane which have at least 90 % biological activity when measured according to Luescher & Glueck, Antiviral Research 14, 39-50. In the membrane, the cholesterol content is preferably less than 2% by weight, the detergent content preferably less than 1 ppb. The vesicle diameter preferably is about 80 nm. The phospholipid in the membrane may comprise 70 to 95 % by weight of phosphatidylcholine and preferably 10 to 20 % by weight of phosphatidylethanolamine; preferably 6 to 8 % by weight of a crosslinker, preferably of a sulfosuccinimidyl derivate, and at least one cell-specific fusion peptide are linked to the membrane. The vesicles are used for the preparation of pharmaceuticals against AIDS and carcinomas. The process for the preparation of phospholipid bi-layer vesicles comprises hemagglutinin as a cell-specific marker with at least one fusion peptide. The hemagglutinin is separated from a virus strain by means of a non-ionic detergent, preferably octaethylene glycol monododecyl ether. It is removed by repeatedly treating the solution with altogether about 1.5 g polystyrene beaded microcarriers per 100 mg detergent.
Patent NO-940632-L (NO)
Inventor: REINKLOU LARS ANDERS
IPC: E04G21/32
Filed: 1994-02-24
Abstract: PCT No. PCT/SE92/00588 Sec. 371 Date Apr. 28, 1994 Sec. 102(e) Date Apr. 28, 1994 PCT Filed Aug. 26, 1992 PCT Pub. No. WO93/04249 PCT Pub. Date Mar. 4, 1993Fitting (1) for forming guard rails of posts or for anchoring guard elements with elongated guard elements, removably mounted in the fittings, such as boards, pipes, aluminum profiles or the like, or guard elements made as protective nets. The fitting (1) comprises an upper (2) and a lower (6) separate main component supporting individual guard elements. The ends (12, 34) of the components (2, 6) facing each other are each provided with a laterally extending lug (14, 36). The lugs are pivotably joined to each other and a clevis is pivotably mounted about the lugs (14, 36) and is provided with an anchoring pin (26) disposed essentially perpendicular to the pivot axis of the lugs.
Patent NO-944900-L (NO)
Inventor: JOHANSSON GUN-BRIT
IPC: B28B23/00
Filed: 1994-12-16
Abstract: In the manufacture of switch-point sleeper blocks of varying lengths and having a varying number of rail attachment devices provided in varying positions therealong, there is used a number of matrices (1) which are placed in a long form bed. The matrices (1) include holes in the region of promontories (10a) and the matrix dishes (3) are inserted in the holes and fastened to the matrices (1). When concrete is poured into the form bed and allowed to harden, concrete sleeper blocks which exhibit promontories (10a) of the said kind are obtained. The invention relates to a matrix provided with a matrix dish (3) and to a matrix array which includes a number of such matrices of varying lengths and with different positions for the matrix dishes (3).
Patent NO-944931-L (NO)
Title: Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet
Inventor: DODGE JEFFREY ALAN
IPC: A61K31/55
Filed: 1994-12-19
Abstract: Anvendelse av en effektiv mengde av en forbindelse som har formelen:. hvor Rog ruavhengig er hydrogen -CHo, alkyl).eller. hvor Ar er eventuelt substituert fenyl;. Rer valgt fra gruppen bestående av pyrrolldino, heksametylenlmlno, og plperldlno; eller et farmasøytisk akseptabelt salt eller solvat derav, for lnhlbering av tidlig seksuell modenhet ved administrasjon til et menneske av en effektiv mengde av nevnte forbindelse.
Patent NO-954014-L (NO)
Inventor: MOOS SIMON
IPC: C02F11/147
Filed: 1995-10-09
Abstract: PCT No. PCT/EP93/02501 Sec. 371 Date Dec. 8, 1995 Sec. 102(e) Date Dec. 8, 1995 PCT Filed Sep. 16, 1993 PCT Pub. No. WO94/24059 PCT Pub. Date Oct. 27, 1994Apparatus for treating and dewatering of sludge taken from small-scale sewage treatment plants. The apparatus, which preferably is mounted on a vehicle, incorporates chamber-type units for dewatering, which can be connected by way of feed and return pipes, controllable valves, and pumps that can be switched on and off. A dewatering vessel with filter walls and separate sludge and filtrate chambers is connectable with a sludge chamber and a filtrate chamber, respectively, of a second dewatering vessel by way of joining pipes comprising at least one feeding pump and one controllable valve each, a radiation chamber arranged in the filtrate return pipe of one of the dewatering vessels, and a stone trap arranged in one other sludge feed pipe.
Patent NO-954116-L (NO)
Inventor: FISCHER ARTUR
IPC: F16B13/08
Filed: 1995-10-16
Abstract: The fixing element (1) has a spreading zone, which is formed from a U-shaped longitudinal groove (5) with a wedge (6) fitted in it. The wedge lies on the base surface of the longitudinal groove, spaced out from the front endface at the outside of the shaft (2). The external surface of the wedge, with teeth (8) projects by at least part of the tooth height from the shaft. The wedge, which can be pushed along the base surface of the longitudinal groove, enables the anchored fixing element to spread after fitting if the borehole should widen due to a crack.
Patent NO-955272-L (NO)
Inventor: AU HANS-RUDOLF AUS DER
IPC: H01B17/26
Filed: 1995-12-22
Abstract: For the manufacture of substantially hollow-cylindrical castings (5), especially leading-in insulators for conductors under high voltage, a more or less liquid casting material (50) is introduced into a substantially hollow-cylindrical casting mould (2) that is driven in rotation. Before the introduction of the casting material, the casting mould is heated to a temperature above the gelling temperature of the casting material. The casting mould (2) filled with casting material (50) is driven in rotation until a casting (5) that is substantially set solid has been formed. The casting so formed is then removed from the casting mould. Before the introduction of the casting material into the casting mould, however, a substantially hollow-cylindrical mesh fabric (1) is introduced into the heated casting mould (2) concentrically to the axis of rotation (22) thereof, and only then is the casting material (50) introduced into the casting mould (2).
Patent NO-960016-L (NO)
Title: Nye acylerte pseudopeptider med trifluormetylsubstituert 2-azabicyklo-oktan
Inventor: RADDATZ SIEGFRIED
IPC: C07K5/06
Filed: 1996-01-03
Abstract: Det blir beskrevet nye acylerte pseudopeptider med trifluormetyl-substituerte 2-azabicyklo-oktan med den generelle formel (I) hvor R1 står for en rest med formel eller N. ;x hvor A, D, E, L og T er Ilke eller forskjellige og står for hydrogen, halogen, rettkjedet eller forgrenet alkyl ned opptil 4 karbonatoner, morfollnyl, fenyltlo eller cykloalkyl med 3 til 6 karbonatomer, R2 står for rettkjedet eller forgrenet acyl ned opptil 20 karbonatomer, som eventuelt er substituert med karboksy, med rettkjedet eller forgrenet alkoksykar- bonyl ned opptil 6 karbonatomer eller med en gruppe med formelen -KR3R4, hvor . R3 og 'R4 er like eller forskjellige og «tar for hydrogen, fenyl eller rettkjedet eller forgrenet alkyl ned opptil 6 karbonatomer, står for en rest med formelen -CO-XR5R6 eller P(0)(OR7)(OR8), hvor R8 og R6 har den ovenfor angitte betydning for R3 og R4 og er Ilke eller forskjellige, R7 og R8 er Ilke eller forskjellige og står for hydrogen eller rettkjedet eller forgrenet alkyl med opptil 4 karbonatomer, eller står for rettkjedet eller forgrenet alkoksy med opptil 6 karbonatomer, som eventuelt er substituert med dlfluormetyl, dlfluormetoksy, trlfluonnetoksy eller trlfluormetyl, eller for en rest med formlene HA c", ^° Hf og deres salter.